Senti Biosciences, Inc. Weighted Average Number of Shares Outstanding, Basic from Q2 2021 to Q3 2025

Taxonomy & unit
us-gaap: shares
Description
Number of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.
Summary
Senti Biosciences, Inc. quarterly/annual Weighted Average Number of Shares Outstanding, Basic history and growth rate from Q2 2021 to Q3 2025.
  • Senti Biosciences, Inc. Weighted Average Number of Shares Outstanding, Basic for the quarter ending September 30, 2025 was 26.2M shares, a 473% increase year-over-year.
  • Senti Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2024 was 4.6M shares, a 3.58% increase from 2023.
  • Senti Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2023 was 4.44M shares, a 83% decline from 2022.
  • Senti Biosciences, Inc. annual Weighted Average Number of Shares Outstanding, Basic for 2022 was 26.1M shares, a 797% increase from 2021.
Weighted Average Number of Shares Outstanding, Basic, Quarterly (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Quarterly Growth (%)
Weighted Average Number of Shares Outstanding, Basic, Annual (shares)
Weighted Average Number of Shares Outstanding, Basic, YoY Annual Growth (%)

Senti Biosciences, Inc. Quarterly Weighted Average Number of Shares Outstanding, Basic (shares)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 26.2M +21.7M +473% Jul 1, 2025 Sep 30, 2025 10-Q 2025-11-13
Q2 2025 26.1M +21.5M +470% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-07
Q1 2025 10M +5.44M +119% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-06
Q4 2024 4.6M +159K +3.58% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-20
Q3 2024 4.58M +130K +2.92% Jul 1, 2024 Sep 30, 2024 10-Q 2025-11-13
Q2 2024 4.57M +144K +3.26% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-07
Q1 2024 4.57M -39.5M -89.6% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-06
Q4 2023 4.44M -21.7M -83% Oct 1, 2023 Dec 31, 2023 10-K 2025-03-20
Q3 2023 4.45M -39M -89.8% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-14
Q2 2023 4.43M -9.02M -67.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-13
Q1 2023 44.1M +40.9M +1290% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 26.1M Oct 1, 2022 Dec 31, 2022 10-K 2024-03-21
Q3 2022 43.4M +40.5M +1384% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-14
Q2 2022 13.4M +10.5M +362% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-11
Q1 2022 3.17M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q3 2021 2.93M Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 2.91M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-15

Senti Biosciences, Inc. Annual Weighted Average Number of Shares Outstanding, Basic (shares)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 4.6M +159K +3.58% Jan 1, 2024 Dec 31, 2024 10-K 2025-03-20
2023 4.44M -21.7M -83% Jan 1, 2023 Dec 31, 2023 10-K 2025-03-20
2022 26.1M +23.2M +797% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 2.91M Jan 1, 2021 Dec 31, 2021 10-K 2023-03-22
* An asterisk sign (*) next to the value indicates that the value is likely invalid.